Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases. β
Go to Publication β
World journal of gastroenterology (World J Gastroenterol ) Vol: 29 Issue 20 Pages: 3048-3065 Pub: 2023 May 28 Epub: Authors Gravina AG , Pellegrino R , Auletta S , Palladino G , Brandimarte G , D`Onofrio R , Arboretto G , Imperio G , Ventura A , Cipullo M , Romano M , Federico A , |
|
|
Modulating effects of Hericium erinaceus polysaccharides on the immune response by regulating gut microbiota in cyclophosphamide-treated mice. β
Go to Publication β
Journal of the science of food and agriculture (J Sci Food Agric ) Vol: 103 Issue 6 Pages: 3050-3064 Pub: 2023 Apr Epub: 2023 Jan 18 Authors Tian B , Liu R , Xu T , Cai M , Mao R , Huang L , Yang K , Zeng X , Peilong S , |
|
|
Auxiliary antitumor effects of fungal proteins from Hericium erinaceus by target on the gut microbiota. β
Go to Publication β
Journal of food science (J Food Sci ) Vol: 85 Issue 6 Pages: 1872-1890 Pub: 2020 Jun Epub: 2020 May 27 Authors Wang D , Zhu X , Tang X , Li H , Yizhen X , Chen D , |
|
|
Lentinula edodes-derived polysaccharide alters the spatial structure of gut microbiota in mice. β
Go to Publication β
PloS one (PLoS One ) Vol: 10 Issue 1 Pages: e0115037 Pub: 2015 Epub: 2015 Jan 21 Authors Xu X , Zhang X , |
|
|
Lentinula edodes-derived polysaccharide alters the spatial structure of gut microbiota in mice. β
Go to Publication β
PloS one (PLoS One ) Vol: 10 Issue 1 Pages: e0115037 Pub: 2015 Epub: 2015 Jan 21 Authors Xu X , Zhang X , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
